MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental

Stavroula Psoni1, Christalena Sofocleous, Joanne Traeger-Synodinos

  • 1Department of Medical Genetics, University of Athens, Aghia Sophia Children's Hospital, Athens, Greece.

Brain & Development
|October 11, 2011
PubMed

Insights

Mutations in the MECP2 gene are common in Rett syndrome (RTT) and related intellectual disabilities. Analyzing MECP2 offers a diagnostic tool for these neurodevelopmental disorders.

Area of Science:

  • Genetics
  • Neurodevelopmental Disorders
  • Molecular Biology

Background:

  • Mutations in the methyl-CpG-binding protein-2 (MECP2) gene cause Rett syndrome (RTT), a neurodevelopmental disorder.
  • MECP2 mutations are also linked to various intellectual disability (MR) phenotypes, including X-linked Mental Retardation (XLMR), Fragile-X-like Syndrome (FXS), and Angelman-like (AS) syndromes.
  • RTT primarily affects females and is characterized by developmental regression and microcephaly.

Purpose of the Study:

  • To determine the incidence and spectrum of MECP2 gene mutations in children with RTT and variant MR.
  • To investigate correlations between MECP2 mutations and clinical phenotypes in affected individuals.

Main Methods:

  • Exons 3-4 of the MECP2 gene were analyzed in 281 patients with MR (144 males, 137 females).
  • Patients were categorized into RTT, AS-like MR, and FXS-like MR groups.
  • Statistical analysis was performed to correlate MECP2 mutation status with clinical features and disease categories.

Main Results:

  • MECP2 mutations were found in approximately 70% of classic RTT cases and 21% of variant RTT cases.
  • Approximately 2.1% of patients with non-specific MR carried MECP2 mutations.
  • MECP2-positive females exhibited more pronounced issues with ambulation, muscle tone, tremor, ataxia, respiratory function, head growth, hand use, and stereotypies compared to MECP2-negative individuals.

Conclusions:

  • MECP2 gene analysis serves as a valuable diagnostic tool for Rett syndrome.
  • The study suggests MECP2 analysis can aid in the research and diagnosis of non-specific intellectual disabilities.
Abstract